Revive Therapeutics Ltd (RVVTF)
0.0188
0.00 (0.00%)
USD |
OTCM |
May 22, 14:32
Revive Therapeutics Max Drawdown (5Y): 97.09% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.09% |
March 31, 2024 | 97.09% |
February 29, 2024 | 97.09% |
January 31, 2024 | 97.09% |
December 31, 2023 | 97.09% |
November 30, 2023 | 97.09% |
October 31, 2023 | 97.09% |
September 30, 2023 | 97.09% |
August 31, 2023 | 97.09% |
July 31, 2023 | 96.56% |
June 30, 2023 | 96.00% |
May 31, 2023 | 96.00% |
April 30, 2023 | 96.00% |
March 31, 2023 | 96.00% |
February 28, 2023 | 96.00% |
January 31, 2023 | 96.00% |
December 31, 2022 | 96.00% |
November 30, 2022 | 96.00% |
October 31, 2022 | 96.00% |
September 30, 2022 | 96.00% |
August 31, 2022 | 96.00% |
July 31, 2022 | 96.00% |
June 30, 2022 | 96.00% |
May 31, 2022 | 96.00% |
April 30, 2022 | 96.00% |
Date | Value |
---|---|
March 31, 2022 | 96.00% |
February 28, 2022 | 96.00% |
January 31, 2022 | 96.00% |
December 31, 2021 | 96.00% |
November 30, 2021 | 96.00% |
October 31, 2021 | 96.00% |
September 30, 2021 | 96.00% |
August 31, 2021 | 96.00% |
July 31, 2021 | 96.00% |
June 30, 2021 | 96.00% |
May 31, 2021 | 96.00% |
April 30, 2021 | 96.00% |
March 31, 2021 | 96.00% |
February 28, 2021 | 96.00% |
January 31, 2021 | 96.00% |
December 31, 2020 | 96.00% |
November 30, 2020 | 96.00% |
October 31, 2020 | 96.00% |
September 30, 2020 | 96.00% |
August 31, 2020 | 96.00% |
July 31, 2020 | 96.00% |
June 30, 2020 | 96.00% |
May 31, 2020 | 96.00% |
April 30, 2020 | 96.00% |
March 31, 2020 | 96.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
85.72%
Minimum
May 2019
97.09%
Maximum
Aug 2023
95.50%
Average
96.00%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -31.36 |
Beta (5Y) | 0.3472 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 138.2% |
Historical Sharpe Ratio (5Y) | -0.199 |
Historical Sortino (5Y) | -0.5683 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.11% |